Matches in Wikidata for { <http://www.wikidata.org/entity/Q91244774> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q91244774 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91244774 description "scientific article published on 30 August 2018" @default.
- Q91244774 description "wetenschappelijk artikel" @default.
- Q91244774 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91244774 name "Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy" @default.
- Q91244774 name "Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy" @default.
- Q91244774 type Item @default.
- Q91244774 label "Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy" @default.
- Q91244774 label "Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy" @default.
- Q91244774 prefLabel "Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy" @default.
- Q91244774 prefLabel "Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy" @default.
- Q91244774 P1104 Q91244774-A6953160-7AAA-4936-BB69-605646190A21 @default.
- Q91244774 P1433 Q91244774-BE92F8E2-A3D3-45F0-9FAF-4EB4396C5C9F @default.
- Q91244774 P1476 Q91244774-5402A1B4-045F-453F-8223-57D52CC9B755 @default.
- Q91244774 P2093 Q91244774-1A5773AD-E1EC-4478-A6D1-5481F46BA408 @default.
- Q91244774 P2093 Q91244774-22B9477F-B106-43F6-AC91-52D1CAD4DE95 @default.
- Q91244774 P2093 Q91244774-444B934F-8E7E-4547-BD32-2F7DA98D2C88 @default.
- Q91244774 P2093 Q91244774-52B72F13-116D-42DD-AA34-E1D45F1D0C5C @default.
- Q91244774 P2093 Q91244774-59DED6AF-B02E-4CBF-802C-D5F214C0F3FA @default.
- Q91244774 P2093 Q91244774-7C93C4F3-3D0E-4045-81B3-E19C51AADE9E @default.
- Q91244774 P2093 Q91244774-9B7CBEA0-0FC9-4DA1-B2C2-9C4A295CD0F2 @default.
- Q91244774 P2093 Q91244774-BFBE6020-AF04-4FEE-8036-75FC93FB3E19 @default.
- Q91244774 P2093 Q91244774-BFCFE147-6F44-4E88-BCD8-C83872CD8D5D @default.
- Q91244774 P2093 Q91244774-F05F7C5B-995B-4E6E-BB58-3B2A6878A926 @default.
- Q91244774 P2093 Q91244774-F3C574BA-2A7A-48FB-B01C-7CFC5383BF5E @default.
- Q91244774 P304 Q91244774-5669C450-6F04-43F8-84D6-60046C4BE2A4 @default.
- Q91244774 P31 Q91244774-B619D560-BE21-4998-9CF8-7368D751AEC3 @default.
- Q91244774 P356 Q91244774-B01A5DEC-B25E-4072-9AD8-41E5B81D57FC @default.
- Q91244774 P433 Q91244774-5F6D1668-73C6-46F0-AE12-E4D025DF0F74 @default.
- Q91244774 P478 Q91244774-3D9AEF88-0E71-4E23-97A2-29FC14E6AD5A @default.
- Q91244774 P50 Q91244774-2BC9A273-01D3-4A8A-85DE-C8776CAEB870 @default.
- Q91244774 P50 Q91244774-C1F270B1-02C6-4BCC-B197-FED67B63AB11 @default.
- Q91244774 P50 Q91244774-C87B6AD3-824F-47EF-B945-654A99CA98D4 @default.
- Q91244774 P50 Q91244774-C8AD395C-606C-4FD7-A7E7-02ED179C17C1 @default.
- Q91244774 P577 Q91244774-D7B823E0-50CD-4349-85C6-6F3BF05B7091 @default.
- Q91244774 P698 Q91244774-41C6C8A3-B9EC-4058-B341-9C8A85BFE1E5 @default.
- Q91244774 P921 Q91244774-113C355D-C276-47A1-88D3-520E6926C719 @default.
- Q91244774 P921 Q91244774-EAD9002C-0872-40E3-BB6D-AA3C502195EF @default.
- Q91244774 P356 BJH.15539 @default.
- Q91244774 P698 30168134 @default.
- Q91244774 P1104 "+11" @default.
- Q91244774 P1433 Q4970200 @default.
- Q91244774 P1476 "Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy" @default.
- Q91244774 P2093 "Ai Sim Goh" @default.
- Q91244774 P2093 "Andreas Engert" @default.
- Q91244774 P2093 "Bastian von Tresckow" @default.
- Q91244774 P2093 "Bingxia Wang" @default.
- Q91244774 P2093 "Dirk Huebner" @default.
- Q91244774 P2093 "Guner Hayri Ozsan" @default.
- Q91244774 P2093 "Jan Koren" @default.
- Q91244774 P2093 "Muhit Ozcan" @default.
- Q91244774 P2093 "Noppadol Siritanaratkul" @default.
- Q91244774 P2093 "Shalini Singh" @default.
- Q91244774 P2093 "Suporn Chuncharunee" @default.
- Q91244774 P304 "400-410" @default.
- Q91244774 P31 Q13442814 @default.
- Q91244774 P356 "10.1111/BJH.15539" @default.
- Q91244774 P433 "3" @default.
- Q91244774 P478 "183" @default.
- Q91244774 P50 Q114419548 @default.
- Q91244774 P50 Q57724597 @default.
- Q91244774 P50 Q59505916 @default.
- Q91244774 P50 Q9152201 @default.
- Q91244774 P577 "2018-08-30T00:00:00Z" @default.
- Q91244774 P698 "30168134" @default.
- Q91244774 P921 Q209369 @default.
- Q91244774 P921 Q65592366 @default.